{
    "id": 11081,
    "fullName": "RET C620R",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "RET C620R lies within the extracellular domain of the Ret protein (PMID: 9230192). C620R results in decreased cell surface Ret expression, but also results in increased Ret and Shc phosphorylation, activation of transcription in a reporter assay, and is transforming in cell culture (PMID: 9879991, PMID: 9230192).",
            "references": [
                {
                    "id": 2271,
                    "pubMedId": 9879991,
                    "title": "Dual effect on the RET receptor of MEN 2 mutations affecting specific extracytoplasmic cysteines.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9879991"
                },
                {
                    "id": 2272,
                    "pubMedId": 9230192,
                    "title": "Biological properties of Ret with cysteine mutations correlate with multiple endocrine neoplasia type 2A, familial medullary thyroid carcinoma, and Hirschsprung's disease phenotype.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9230192"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5979,
        "geneSymbol": "RET",
        "terms": [
            "RET",
            "CDHF12",
            "CDHR16",
            "HSCR1",
            "MEN2A",
            "MEN2B",
            "MTC1",
            "PTC",
            "RET-ELE1"
        ]
    },
    "variant": "C620R",
    "createDate": "08/31/2015",
    "updateDate": "12/08/2018",
    "referenceTranscriptCoordinates": {
        "id": 125205,
        "transcript": "NM_020975",
        "gDna": "chr10:g.43113654T>C",
        "cDna": "c.1858T>C",
        "protein": "p.C620R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 3373,
            "approvalStatus": "Phase II",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a Phase II clinical trial, Afinitor (everolimus) treatment resulted in stable disease of 116 weeks in a MEN2A patient with medullary thyroid cancer carrying a RET C620R mutation (PMID: 26294908).",
            "molecularProfile": {
                "id": 11125,
                "profileName": "RET C620R"
            },
            "therapy": {
                "id": 735,
                "therapyName": "Everolimus",
                "synonyms": null
            },
            "indication": {
                "id": 3973,
                "name": "thyroid gland medullary carcinoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3764,
                    "pubMedId": 26294908,
                    "title": "Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26294908"
                }
            ],
            "ampCapAscoEvidenceLevel": "B",
            "ampCapAscoInferredTier": "I"
        }
    ],
    "molecularProfiles": [
        {
            "id": 11125,
            "profileName": "RET C620R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 125205,
            "transcript": "NM_020975",
            "gDna": "chr10:g.43113654T>C",
            "cDna": "c.1858T>C",
            "protein": "p.C620R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 125206,
            "transcript": "NM_020630",
            "gDna": "chr10:g.43113654T>C",
            "cDna": "c.1858T>C",
            "protein": "p.C620R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}